An imidazoline compound completely counteracts interleukin-1β toxic effects to rat pancreatic islet β cells

Molecular Medicine

Volumn 8, Issue 9, 2002, Pages 536-545

  Papaccio, Gianpaolo ^a   Nicoletti, Ferdinando ^b   Pisanti, Francesco A ^c   Galdieri, Michela ^a   Bendtzen, Klaus ^d  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF CALABRIA   (Italy)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FREE RADICAL; HYDROGEN PEROXIDE; IMIDAZOLINE DERIVATIVE; INSULIN; INTERLEUKIN 1BETA; MANGANESE SUPEROXIDE DISMUTASE; MANGANESEDICHLORO(3,10,13,20,26 PENTAAZATETRACYCLO[20.3.1.0(4,9).0(14,19)] 1(26),22(23),24 HEXACOSATRIENE); MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROGEN RADICAL; OXYGEN RADICAL; REACTIVE NITROGEN SPECIES; RX 871024; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DNA CONTENT; DNA SYNTHESIS; DRUG ANTAGONISM; DRUG MECHANISM; ENZYME ACTIVITY; GENE INDUCTION; GENETIC TRANSCRIPTION; INSULIN RELEASE; LIPID PEROXIDATION; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0036765850     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402163     Document Type: Article

References (40)

1. Bendtzen K, Mandrup-Poulsen T, Nerup J, et al. (1986) Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232: 1545-1547.
2. Sandler S, Andersson A, Hellerstrom C. (1987) Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 121: 1424-1431.
3. Mandrup-Poulsen T, Egeberg J, Nerup J, et al. (1987) Ultra-structural studies of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity. Acta Pathol. Microbiol. Immunol. Scand. Sect. C 95: 55-63.
4. Rabinovitch A, Baquerizo H, Sumoski W. (1990) Cytotoxic effects of cytokines on islet beta-cells: evidence for involvement of eicosanoids. Endocrinology 126: 67-71.
5. Loweth AC, Williams GT, James RF, et al. (1998) Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation. Diabetes 47: 727-732.
6. Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J. (1987) Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic β-cell cytotoxicity. J. Immunol. 139: 4077-4082.
7. Pukel C, Baquerizo H, RAbinovitch A. (1988) Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 37: 133-136.
8. Eizirik DL, Flodström M, Karlsen AE, Welsh N. (1996) The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 39: 875-890.
9. Malaisse WJ, Malaisse-Lagae F, Sener A, Pipeleers DG. (1982) Determinants of the selective toxicity of alloxan to the pancreatic B cell. Proc. Natl. Acad. Sci. USA 79: 927-930.
10. Gandy SE, Buse MG, Crouch RK. (1982) Protective role of superoxide dismutase against diabetogenic drugs. J. Clin Invest. 70: 650-658.
11. Nerup J, Mandrup-Poulsen T, Mølvig J, et al. (1988) Mechanisms of pancreatic beta-cell destruction in type I diabetes. Diab. Care 11 (Suppl. 1), 16-23.
12. Sumoski W, Baquerizo H, Rabinovitch A. (1989) Oxygen free radical scavengers protect rat islet cells from damage by cytokines. Diabetologia 32: 792-796.
13. Papaccio G. (1991) Prevention of low dose streptozotocin-induced diabetes by acetyl- homocysteine-thiolactone. Diabetes Res. Clin. Pract. 13: 95-102.
14. Grankvist K, Marklund SL, Taljedal IB. (1981) CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem. J. 199: 393-398.
15. Papaccio G, Pisanti FA, Frascatore S. (1986) Acetyl-homocysteine-thiolactone-induced increase of superoxide dismutase counteracts the effect of subdiabetogenic doses of streptozocin. Diabetes 35: 470-474.
16. Pisanti FA, Frascatore S, Papaccio G. (1988) Superoxide dismutase activity in the BB rat: a dynamic time-course study. Life Sci. 43: 1625-1632.
17. Papaccio G, Frascatore S, Pisanti FA, et al. (1995) Superoxide dismutase in the nonobese diabetic (NOD) mouse: a dynamic time-course study. Life Sci. 56: 2223-2228.
18. Borg LAH, Cagliero E, Sandler S, et al. (1992) Interleukin-1β increases the activity of superoxide dismutase in rat pancreatic islets. Endocrinology 130: 2851-2857.
19. Nicoletti F, Di Marco R, Barcellini W, et al. (1994) Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor. Eur. J. Immunol. 24: 1843-1847.
20. Wilson GL, Patton NJ, LeDoux SP. (1997) Mitochondrial DNA in beta-cells is a sensitive target for damage by nitric oxide. Diabetes 46: 1291-1295.
21. Delaney CA, Green MH, Lowe JE, Green IC. (1993) Endogenous nitric oxide induced by interleukin-1β in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the 'comet' assay. FEBS Lett. 333: 291-295.
22. Zaitsev SV, Efanov AM, Efanova IB, et al. (1996) Imidazoline compounds stimulate insulin release by inhibition of K(ATP) channels and interaction with the exocytotic machinery. Diabetes 45: 1610-1618.
23. Efanov AM, Zaitsev SV, Berggren PO, Mest HJ, Efendic S. (2001) Imidazoline RX871024 raises diacylglycerol levels in rat pancreatic islets. Biochem. Biophys. Res. Commun. 281: 1070-1073.
24. Zaitsev SV, Appelskog IB, Kapelioukh IL, et al. (2001) Imidazoline compounds protect against interleukin 1β-induced beta-cell apoptosis. Diabetes 50 (Suppl 1): S70-S76.
25. 2+ concentration. J. Biol. Chem. 273: 33501-33507.
26. Eizirik DL, Flodstrom M, Karlsen AE, Welsh N. (1996) The harmony of the spheres: inducible nitric oxide sythase and related genes in pancreatic beta cells. Diabetologia 39: 875-890.
27. Sjöholm Å. (1998) Aspects of the involvement of interleukin-1 and nitric oxide in the pathogenesis of insulin-dependent diabetes mellitus. Cell. Death. Differ. 5: 461-468.
28. Salvemini D, Mazzon E, Dugo L, et al. (2001) Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403. Br J. Pharmacol 132: 815-827.
29. Ling Z, In't Veld PA, Pipeleers DG. (1993) Interaction of interleukin-1 with islet β-cells. Distinction between indirect, aspecific cytotoxicity and direct, specific functional suppression. Diabetes 42: 56-65.
30. McCord JM, Fridovich I. (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244: 6049-6055.
31. Hohmeier HE, Thigpen A, Tran VV, et al. (1998) Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1β-induced cytotoxicity and reduces nitric oxide production. J. Clin. Invest. 101: 1811-1820.
32. Papaccio G, Pisanti FA, Latronico MVG, et al. (2000) Multiple low-dose and single high-dose treatments with streptozocin do not generate nitric oxide. J. Cell. Biochem. 77: 82-91.
33. Southern C, Schulster D, Green IC. (1990) Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-α via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 276: 42-44.
34. Welsh N, Eizirik DL, Bendtzen K, Sandler S. (1991) Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the krebs cycle enzyme aconitase. Endocrinology 129: 3167-3173.
35. Moncada S, Palmer RMJ, Higgs EA. (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142.
36. Beckman JS, Bechman TW, Chen J, et al. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl. Acad. Sci. USA 87: 1620-1624.
37. Masuda A, Longo DL, Kobayashi Y, et al. (1988) Induction of mitochondrial manganese superoxide dismutase by interleukin 1. Faseb. J. 2: 3087-3091.
38. Wong GH, Goeddel DV. (1988) Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242: 941-944.
39. Efanov AM, Appelskog IB, Abdel-Halim SM, et al. (2002) Insulinotropic activity of the imidazoline derivative RX871024 in the diabetic GK rat. Am. J. Pysiol. Endcorinol. and Metabolism 282:E117-E124.
40. Regunathan S, Feinstein DL, Reis DJ. (1999) Anti-proliferative and anti-inflammatory actions of imidazoline agents: are imidazoline receptors involved? Ann. N. Y. Acad. Sci. 881: 410-419.